Islet cell failure in type 2 diabetes
Open accessThe DOI matches its Crossref record; 134 of the 134 references it cites were found in a registry or an index; none of the 272 sources its claims cite is checked for support yet.
Abstract
The major focus of this Review is on the mechanisms of islet beta cell failure in the pathogenesis of obesity-associated type 2 diabetes (T2D). As this demise occurs within the context of beta cell compensation for insulin resistance, consideration is also given to the mechanisms involved in the compensation process, including mechanisms for expansion of beta cell mass and for enhanced beta cell performance. The importance of genetic, intrauterine, and environmental factors in the determination of "susceptible" islets and overall risk for T2D is reviewed. The likely mechanisms of beta cell failure are discussed within the two broad categories: those with initiation and those with progression roles.
Overview
CoChat Summary
## TL;DR
This is a 2006 review arguing that type 2 diabetes develops when insulin-resistant islets can no longer sustain compensatory b cell function, leading first to dysfunction and then progressive loss of b cell mass. It emphasizes that “susceptible” islets are shaped by genetic, intrauterine, and environmental factors, and that hyperglycemia accelerates damage through glucotoxic and glucolipotoxic mechanisms.
## Key findings
- In longitudinal studies, insulin levels rise during the normoglycemic and prediabetes phases and then decline when fasting glycemia exceeds the upper normal limit of 5.5 mM, marking b cell failure.
- A longitudinal study in Pima Indians found that b cell dysfunction was the major determinant of progression from normoglycemia to diabetes.
- In autopsy pancreata from 124 subjects, the paper reports a 40% and 63% loss of islet b cell volume in obese subjects with impaired fasting glucose and T2D, respectively, compared with weight-matched controls; lean T2D subjects had a 41% loss versus lean controls.
- The paper reports that the STOP-NIDDM trial showed acarbose treatment of IGT subjects reduced the risk of progression to diabetes by 36%.
## Methods
- Narrative review of mechanistic, animal, human postmortem, genetic, and epidemiologic studies on islet b cell compensation and failure in obesity-associated T2D.
- Synthesizes findings from rodent models (including ZF, ZDF, DBA2, GK, and IUGR models) and human islet/pancreas studies, including a transcript profiling study of 7 normal and 5 T2D human islet samples.
- Main analysis is integrative and conceptual: it organizes evidence into mechanisms that promote compensation and mechanisms with initiation versus progression roles in b cell failure.
## Limitations
- The paper states that the mechanisms of b cell compensation are “not fully understood,” and that the role of several proposed factors remains to be established or warrants further investigation.
- It explicitly notes uncertainty about several mechanisms, including whether nonimmune islet inflammation contributes in vivo, whether IAPP is causal in b cell dysfunction and demise, and whether reduced ARNT expression is an early defect or a consequence.
- Evident from the text: this is a review, not a new experimental study, so its conclusions depend on the quality and consistency of the cited animal and human studies rather than on a single primary dataset.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
0 Valid · 1 Not valid · 164 Not checked · 38 Own results and interpretations
In the paper
“Longitudinal studies of subjects that develop T2D show a rise in insulin levels in the normoglycemic and prediabetes phases that keep glycemia near normal despite the insulin resistance ( b cell compensation), followed by a decline when fasting glycemia surpasses the upper limit of normal of 5.5 mM ( b cell failure) (5) (Figure 1).”
What the sources say
- Not checked yetcites [5]
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“With respect to the latter, increases were observed in enzymes and metabolites involved in anaplerosis and the malate-pyruvate and citratepyruvate shuttles of ZF islets (12).”
What the sources say
- Not checked yetcites [12]
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“Inhibition of these pathways by phenylacetic acid, which inhibits PC, markedly impeded GSIS (12).”
What the sources say
- Not checked yetcites [12]
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
None of the sources cited for this claim have been checked yet.
In the paper
“Studies of islet b cell compensation within models that maintain normoglycemia show upregulation of glucose metabolism pathways (12, 13, 31).”
What the sources say
- Not checked yetcites [12]
- Not checked yetcites [13]
- Not checked yetcites [31]
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
In the paper
“A recent study in Zucker fatty (ZF) rats has provided strong support for PKB activation in the b cell growth response to insulin resistance in this normoglycemic model (11).”
What the sources say
- Not checked yetcites [11]
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
116 more claims
Create a free account to see all 203 claims and to verify the 272 references still open.
- It may state two separate claims as one. 71
- Probably not a substantial claim. 13
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Importantly, several of these studies have demonstrated that fatty acids do not induce beta-cell dysfunction in the absence of elevated glucose, highlighting that fatty acids and glucose are not cytotoxic independently.168,169”
From A review of current trends with type 2 diabetes epidemiology, aetiology, pathogenesis, treatments and future perspectives (2021) · cites this paper as [169]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Notably, impairment of insulin secretion in the presence of an intact β-cell mass also occurs in the early stages of human age-related diabetes123.”
From The telomere syndromes (2012) · cites this paper as [123]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Minor deficiencies in the β-cell machinery may only be exposed in times of metabolic stress, such as pregnancy [75].”
From The Pathophysiology of Gestational Diabetes Mellitus (2018) · cites this paper as [75]
Experimental — accuracy not yet measured
Citations
Cites
Mootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197
Global and societal implications of the diabetes epidemic
Zimmet, P., Alberti, K. G. M. M., & Shaw, J. (2001) · Nature · doi:10.1038/414782a · Cited by 5,883
β-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 Diabetes
Butler, A. E., Janson, J., Bonner-Weir, S., Ritzel, R., Rizza, R. A., & Butler, P. C. (2003) · Diabetes · doi:10.2337/diabetes.52.1.102 · Cited by 4,011
Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial
Chiasson, J.-L., Josse, R. G., Gomis, R., Hanefeld, M., Karasik, A., & Laakso, M. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08905-5 · Cited by 2,543
Barker, D. J. P., Hales, C. N., Fall, C. H. D., Osmond, C., Phipps, K., & Clark, P. M. S. (1993) · Diabetologia · doi:10.1007/bf00399095 · Cited by 2,468
Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes
Grant, S. F. A., Thorleifsson, G., Reynisdottir, I., Benediktsson, R., Manolescu, A., Sainz, J., Helgason, A., Stefansson, H., Emilsson, V., Helgadottir, A., et al. (2006) · Nature Genetics · doi:10.1038/ng1732 · Cited by 2,287
The biology of incretin hormones
Drucker, D. J. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.01.004 · Cited by 2,210
Mitochondrial dysfunction and type 2 diabetes
Lowell, B. B., & Shulman, G. I. (2005) · Science · doi:10.1126/science.1104343 · Cited by 2,070
Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase
Minokoshi, Y., Kim, Y.-B., Peroni, O. D., Fryer, L. G. D., Müller, C., Carling, D., & Kahn, B. B. (2002) · Nature · doi:10.1038/415339a · Cited by 2,053
Weyer, C., Bogardus, C., Mott, D. M., & Pratley, R. E. (1999) · Journal of Clinical Investigation · doi:10.1172/jci7231 · Cited by 1,940
Cited by
Items 401–500 of 1,002
Tuohetaerbaike, B., Zhang, Y., Tian, Y., Zhang, N. N., Kang, J., Mao, X., Zhang, Y., & Li, X. (2019) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2019.112479 · Cited by 69
Flavonoids modulate tight junction barrier functions in hyperglycemic human intestinal Caco-2 cells
Sharma, S., Tripathi, P., Sharma, J., & Dixit, A. (2020) · Nutrition · doi:10.1016/j.nut.2020.110792 · Cited by 69
Incretin-Modulated Beta Cell Energetics in Intact Islets of Langerhans
Hodson, D. J., Tarasov, A. I., Gimeno Brias, S., Mitchell, R. K., Johnston, N. R., Haghollahi, S., Cane, M. C., Bugliani, M., Marchetti, P., Bosco, D., et al. (2014) · Molecular Endocrinology · doi:10.1210/me.2014-1038 · Cited by 62
Duration of Abdominal Obesity Beginning in Young Adulthood and Incident Diabetes Through Middle Age
Reis, J. P., Hankinson, A. L., Loria, C. M., Lewis, C. E., Powell‐Wiley, T. M., Wei, G. S., & Liu, K. (2012) · Diabetes Care · doi:10.2337/dc12-1714 · Cited by 70
“The normal pancreatic b-cell response to obesity-associated insulin resistance is compensatory insulin hypersecretion in order to maintain normoglycemia (27).”
BackgroundSeo, E., Lee, E. K., Lee, C.-S., Chun, K., Lee, M.-Y., & Jun, H. (2014) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2014/897296 · Cited by 67
Wu, Y., Wu, T., Wu, J., Zhao, L., Li, Q., Varghese, Z., Moorhead, J. F., Powis, S. H., Chen, Y., & Ruan, X. Z. (2013) · Journal of Endocrinology · doi:10.1530/joe-13-0160 · Cited by 62
“Decoding the relationship between obesity and diabetes requires complex interdisciplinary research on the cellular mechanisms that link the two conditions (Prentki & Nolan 2006, Eckel et al. 2011).”
BackgroundThe role of autophagy in β ‐cell lipotoxicity and type 2 diabetes
Las, G., & Shirihai, O. S. (2010) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2010.01268.x · Cited by 62
Targeting pancreatic β cells for diabetes treatment
Jain, C., Ansarullah, M., Bilekova, S., & Lickert, H. (2022) · Nature Metabolism · doi:10.1038/s42255-022-00618-5 · Cited by 71
Yao, X., Chen, F., Li, P., Quan, L., Chen, J., Liang, Y., Ding, H., Li, C., Chen, L., Gao, Z., et al. (2013) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2013.08.043 · Cited by 63
Moderate Hypoxia Induces β-Cell Dysfunction with HIF-1–Independent Gene Expression Changes
Sato, Y., Inoue, M., Yoshizawa, T., & Yamagata, K. (2014) · PLoS ONE · doi:10.1371/journal.pone.0114868 · Cited by 72
“understood, oxidative stress, endoplasmic reticulum (ER) stress, and inflammatory stress are considered to be involved in b-cell failure [1, 2].”
BackgroundAndreazzi, A. E., Scomparin, D. X., Mesquita, F., Balbo, S. L., Gravena, C., de Oliveira, J. C., Rinaldi, W., Garcia, R. M. G., Grassiolli, S., & Mathias, P. C. D. F. (2009) · Journal of Endocrinology · doi:10.1677/joe-08-0312 · Cited by 66
Fu, J., Cui, Q., Yang, B., Hou, Y., Wang, H., Xu, Y., Wang, D., Zhang, Q., & Pi, J. (2016) · Food and Chemical Toxicology · doi:10.1016/j.fct.2016.12.016 · Cited by 66
Parim, B., Uddandrao, V. V. S., Vadivukkarasi, S., Naik, R. R., Pothani, S., Begum, M. S., Rajeshkumar, M. P., Varatharaju, C., Meriga, B., Rameshreddy, P., et al. (2017) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-017-2994-0 · Cited by 63
Brunham, L. R., Kruit, J. K., Hayden, M. R., & Verchere, C. B. (2010) · Current Diabetes Reports · doi:10.1007/s11892-009-0090-x · Cited by 67
Mechanisms of β‐cell functional adaptation to changes in workload
Wortham, M., & Sander, M. (2016) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12729 · Cited by 71
“and failure in the progression to T2D involves diverse cellular insults and has been reviewed in detail elsewhere.(2,51) Of note, several metabolic defects contributing to dysfunctional GSIS have been described”
BackgroundNutrient Excess Stimulates β-Cell Neogenesis in Zebrafish
Maddison, L. A., & Chen, W. (2012) · Diabetes · doi:10.2337/db11-1841 · Cited by 62
Protection from β-cell apoptosis by inhibition of TGF-β/Smad3 signaling
Lee, J.-H., Mellado‐Gil, J. M., Bahn, Y. J., Pathy, S. M., Zhang, Y. E., & Rane, S. G. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2365-8 · Cited by 67
Saxagliptin: A Clinical Review in the Treatment of Type 2 Diabetes Mellitus
Kania, D. S., Gonzalvo, J. D., & Weber, Z. (2011) · Clinical Therapeutics · doi:10.1016/j.clinthera.2011.06.016 · Cited by 61
Impact of Small-Molecule Glucokinase Activator on Glucose Metabolism and β-Cell Mass
Nakamura, A., Terauchi, Y., Ohyama, S., Kubota, J., Shimazaki, H., Nambu, T., Takamoto, I., Kubota, N., Eiki, J., Yoshioka, N., et al. (2008) · Endocrinology · doi:10.1210/en.2008-1183 · Cited by 67
Antidiabetic Actions of an Estrogen Receptor β Selective Agonist
Alonso‐Magdalena, P., Ropero, A. B., García‐Arévalo, M., Soriano, S., Quesada, I., Muhammed, S. J., Salehi, A. A., Gustafsson, J.-Α., & Nadal, Á. (2013) · Diabetes · doi:10.2337/db12-1562 · Cited by 67
Sorcin Links Pancreatic β-Cell Lipotoxicity to ER Ca2+ Stores
Marmugi, A., Parnis, J., Chen, X., Carmichael, L., Hardy, J., Mannan, N. S., Marchetti, P., Piemonti, L., Bosco, D., Johnson, P., et al. (2016) · Diabetes · doi:10.2337/db15-1334 · Cited by 72
“During the progression of obesity and insulin resistance, pancreatic islets of Langerhans initially increase b-cell mass and overproduce insulin (1).”
BackgroundSIRT6 protects against palmitate-induced pancreatic β-cell dysfunction and apoptosis
Xiong, X., Sun, X., Wang, Q., Qian, X., Zhang, Y., Pan, X., & Dong, X. C. (2016) · Journal of Endocrinology · doi:10.1530/joe-16-0317 · Cited by 69
Robiou-du-Pont, S., Bonnefond, A., Yengo, L., Vaillant, E., Lobbens, S., Durand, E., Weill, J., Lantieri, O., Balkau, B., Charpentier, G., et al. (2012) · International Journal of Obesity · doi:10.1038/ijo.2012.175 · Cited by 63
Effect of Environmental Contaminants on Beta Cell Function
Makaji, E., Raha, S., Wade, M. G., & Holloway, A. C. (2011) · International Journal of Toxicology · doi:10.1177/1091581811405544 · Cited by 60
β-Arrestin2 plays a key role in the modulation of the pancreatic beta cell mass in mice
Ravier, M. A., Leduc, M., Richard, J., Linck, N., Varrault, A., Pirot, N., Roussel, M., Bockaert, J., Dalle, S., & Bertrand, G. (2013) · Diabetologia · doi:10.1007/s00125-013-3130-7 · Cited by 63
Modulating GPR40: therapeutic promise and potential in diabetes
Poitout, V., & Lin, D. C.-H. (2013) · Drug Discovery Today · doi:10.1016/j.drudis.2013.09.003 · Cited by 62
Hill, A. A., Anderson‐Baucum, E. K., Kennedy, A. J., Webb, C. D., Yull, F. E., & Hasty, A. H. (2015) · Molecular Metabolism · doi:10.1016/j.molmet.2015.07.005 · Cited by 75
“demand for the production of insulin causes increased cellular stress and this, coupled with exposure to excessive lipids from AT, can result in β cell dysfunction and death (10).”
BackgroundZarrouki, B., Benterki, I., Fontès, G., Peyot, M., Šeda, O., Prentki, M., & Poitout, V. (2013) · Diabetes · doi:10.2337/db13-0425 · Cited by 67
Self-citationDifferential Effects of Protein Kinase B/Akt Isoforms on Glucose Homeostasis and Islet Mass
Buzzi, F., Xu, L., Zuellig, R. A., Boller, S., Spinas, G. A., Hynx, D., Chang, Z., Yang, Z., Hemmings, B. A., Tschopp, O., et al. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.00719-09 · Cited by 63
Pathways governing development of stem cell‐derived pancreatic β cells: lessons from embryogenesis
Al‐Khawaga, S., Memon, B., Butler, A. E., Taheri, S., Abou‐Samra, A., & Abdelalim, E. M. (2017) · Biological reviews/Biological reviews of the Cambridge Philosophical Society · doi:10.1111/brv.12349 · Cited by 64
“These toxic oligomers compromise β-cell function and cause a progressive reduction of the pancreatic β-cell mass by inducing β-cell apoptosis (Butler et al., 2003; Prentki & Nolan, 2006; Poitout & Robertson, 2008; Costes et al., 2013).”
BackgroundHyperlipidemia-Induced MicroRNA-155-5p Improves β-Cell Function by TargetingMafb
Zhu, M., Wei, Y., Geißler, C., Abschlag, K., Corbalán-Campos, J., Hristov, M., Möllmann, J., Lehrke, M., Karshovska, E., & Schober, A. (2017) · Diabetes · doi:10.2337/db17-0313 · Cited by 65
Levasseur, E. M., Yamada, K., Piñeros, A. R., Wu, W., Syed, F., Orr, K. S., Anderson-Baucum, E., Mastracci, T. L., Maier, B., Mosley, A. L., et al. (2019) · Science Signaling · doi:10.1126/scisignal.aax0715 · Cited by 58
Oshima, M., Pechberty, S., Bellini, L., Göpel, S., Campaña, M. B., Rouch, C., Dairou, J., Cosentino, C., Fantuzzi, F., Toivonen, S., et al. (2019) · Diabetologia · doi:10.1007/s00125-019-05046-x · Cited by 59
Jiang, S., Shen, D., Jia, W., Han, X., Shen, N., Tao, W., Gao, X., Xue, B., & Li, C. (2015) · The Journal of Pathology · doi:10.1002/path.4652 · Cited by 57
Delghingaro-Augusto, V., Nolan, C. J., Gupta, D., Jetton, T. L., Latour, M. G., Peshavaria, M., Madiraju, S. R. M., Joly, É., Peyot, M.-L., Prentki, M., et al. (2009) · Diabetologia · doi:10.1007/s00125-009-1317-8 · Cited by 57
Self-citationLamont, B. J., Waters, M. F., & Andrikopoulos, S. (2016) · Nutrition & Diabetes · doi:10.1038/nutd.2016.2 · Cited by 57
Choi, S. W., & Ho, C. K. (2018) · Redox Report · doi:10.1080/13510002.2017.1324381 · Cited by 57
The role of beta cell heterogeneity in islet function and insulin release
Nasteska, D., & Hodson, D. J. (2018) · Journal of Molecular Endocrinology · doi:10.1530/jme-18-0011 · Cited by 65
Li, S., Huang, Q., Zhang, L., Qiao, X., Zhang, Y., Tang, F., & Li, Z. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.03.027 · Cited by 61
“These changes indicated that T2DM mice model was built successfully (Morris et al., 2016; Borai et al., 2007; Prentki and Nolan, 2006).”
BackgroundHellemans, K., Kerckhofs, K., Hannaert, J. C., Martens, G. A., Veldhoven, P. P. V., & PIPELEERS, D. G. (2007) · FEBS Journal · doi:10.1111/j.1742-4658.2007.06131.x · Cited by 63
Costes, S., Vandewalle, B., Tourrel‐Cuzin, C., Broca, C., Linck, N., Bertrand, G., Kerr-Conte, J. A., Portha, B., Pattou, F. N., Bockaert, J., et al. (2009) · Diabetes · doi:10.2337/db08-0926 · Cited by 64
de Souza, C. O., Sun, X., & Oh, D. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.715877 · Cited by 72
“Therefore, insulin resistance and lower insulin secretion are the two coexisting pathophysiological markers in most patients with T2D (2, 4, 5).”
BackgroundChoi, S., Jung, I., Lee, Y.-J., Lee, S., Lee, J.-H., Kim, Y., Jun, H., Lee, K. W., Park, C. B., & KANG, Y. Y. (2011) · Endocrinology · doi:10.1210/en.2010-0924 · Cited by 61
The role of insulin signaling in the development of β-cell dysfunction and diabetes
Wang, Q., & Jin, T. (2009) · Islets · doi:10.4161/isl.1.2.9263 · Cited by 64
He, M., Su, H., Gao, W., Johansson, S. M., Liu, Q., Wu, X., Liao, J., Young, A. A., Bartfai, T., & Wang, M.-W. (2010) · PLoS ONE · doi:10.1371/journal.pone.0014205 · Cited by 56
No Islets Left Behind: Islet Autotransplantation for Surgery-Induced Diabetes
Bellin, M. D., Balamurugan, A. N., Pruett, T. L., & Sutherland, D. E. R. (2012) · Current Diabetes Reports · doi:10.1007/s11892-012-0296-1 · Cited by 59
Somesh, B. P., Verma, M. K., Sadasivuni, M. K., Oommen, A. M., Biswas, S., Shilpa, P. C., Reddy, A. K., Yateesh, A. N., Pallavi, P. M., Siddaraju, N., et al. (2013) · BMC Cell Biology · doi:10.1186/1471-2121-14-31 · Cited by 61
“Background Type 2 diabetes mellitus (T2DM) is a metabolic disorder in which pancreatic insulin secretion does not meet the demands of insulin sensitivity [1,2].”
BackgroundFeng, Y., Guan, X.-M., Li, J., Metzger, J. M., Zhu, Y., Juhl, K., Zhang, B. B., Thornberry, N. A., Reitman, M. L., & Zhou, Y.-P. (2011) · Endocrinology · doi:10.1210/en.2011-1440 · Cited by 59
Rapid Elevation in CMPF May Act As a Tipping Point in Diabetes Development
Liu, Y., Prentice, K. J., Eversley, J. A., Hu, C., Batchuluun, B., Leavey, K., Hansen, J. B., Wei, D. W., Cox, B., Dai, F. F., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.02.079 · Cited by 59
“It has been suggested that chronic factors, including glucolipotoxicity, inflammation, endoplasmic reticulum (ER) stress, and/or oxidative stress may collectively exhaust the beta cell compensatory capacity, reducing beta cell mass and insulin secretion over time until compensation is no longer feasible (Abdul-Ghani e…”
BackgroundErukainure, O. L., Hafizur, R. M., Kabir, N., Choudhary, M. I., Atolanı, O., Banerjee, P., Preißner, R., Chukwuma, C. I., Muhammad, A. I., Amonsou, E. O., et al. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00008 · Cited by 60
Scoville, D. W., Kang, H. S., & Jetten, A. M. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107632 · Cited by 60
“Loss or dysfunction of β-cells leads to insufficient secretion of insulin, and results in hyperglycemia and eventual diabetes (DiMeglio, EvansMolina, & Oram, 2018; Letourneau & Greeley, 2018; Prentki & Nolan, 2006; Roden & Shulman, 2019).”
BackgroundThe big problem: battling companion animal obesity
Raffan, E. (2013) · Veterinary Record · doi:10.1136/vr.f5815 · Cited by 61
Increased glycolysis affects β-cell function and identity in aging and diabetes
Murao, N., Yokoi, N., Takahashi, H., Hayami, T., Minami, Y., & Seino, S. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101414 · Cited by 61
Protective Action of Liraglutide in Beta Cells Under Lipotoxic Stress Via PI3K/Akt/FoxO1 Pathway
Shao, S., Nie, M., Chen, C., Chen, X., Zhang, M., Yuan, G., Yu, X., & Yang, Y. (2014) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24763 · Cited by 55
Lee, J., Wang, P., Yang, I.-H., Huang, H., Chang, C., Wu, C., & Chuang, J. (2015) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.15-16504 · Cited by 61
Hanley, A. J., Zinman, B., Sheridan, P., Yusuf, S., Gerstein, H. C., & for the Diabetes Reduction Assessment With Ramipril and Rosiglitazone Medication (DREAM) Investigators (2010) · Diabetes Care · doi:10.2337/dc09-1579 · Cited by 55
Protection of Pancreatic β-Cells from Various Stress Conditions Is Mediated by DJ-1
Inberg, A., & Linial, M. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.109751 · Cited by 59
Rgs16 and Rgs8 in embryonic endocrine pancreas and mouse models of diabetes
Villasenor, A., Wang, Z. V., Rivera, L. B., Ocal, O., Asterholm, I. W., Scherer, P. E., Brekken, R. A., Cleaver, O., & Wilkie, T. M. (2010) · Disease Models & Mechanisms · doi:10.1242/dmm.003210 · Cited by 55
Mugabo, Y., Zhao, S., Lamontagne, J., Al‐Mass, A., Peyot, M., Corkey, B. E., Joly, E. C., Madiraju, S. R. M., & Prentki, M. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.763060 · Cited by 58
Self-citationWu, Y., Li, Y., Liao, X., Wang, Z., Li, R., Zou, S., Jiang, T., Zheng, B., Duan, P., & Xiao, J. (2017) · International Journal of Biological Sciences · doi:10.7150/ijbs.21172 · Cited by 61
Serotonin Regulates Adult β-Cell Mass by Stimulating Perinatal β-Cell Proliferation
Moon, J. H., Kim, Y. G., Kim, K., Osonoi, S., Wang, S., Saunders, D. C., Wang, J., Yang, K., Kim, H., Lee, J., et al. (2020) · Diabetes · doi:10.2337/db19-0546 · Cited by 54
Ezzat, S. M., Bishbishy, M. H. E., Aborehab, N. M., Salama, M. M., Hashish, A. F., Motaal, A. A. A., Rashad, H. M., & Metwally, F. M. (2020) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2020.112541 · Cited by 69
Jaikumkao, K., Promsan, S., Thongnak, L., Swe, M. T., Tapanya, M., Htun, K. T., Kothan, S., Intachai, N., & Lungkaphin, A. (2021) · Journal of Cellular Physiology · doi:10.1002/jcp.30316 · Cited by 58
“Pancreatic β‐cells are declarative to an augmented insulin secretory accounts for a high requirement on endoplasmic reticulum (ER) for the production of proinsulin, primary to ER stress (Prentki & Nolan, 2006).”
BackgroundLamontagne, J., Pepin, E., Peyot, M.-L., Joly, E., Ruderman, N. B., Poitout, V., Madiraju, S. R. M., Nolan, C. J., & Prentki, M. (2009) · Endocrinology · doi:10.1210/en.2008-1557 · Cited by 55
Self-citationPeiris, H. S., Raghupathi, R., Jessup, C. F., Zanin, M., Mohanasundaram, D., Mackenzie, K. D., Chataway, T., Clarke, J. N., Brealey, J. K., Coates, P. T., et al. (2012) · Endocrinology · doi:10.1210/en.2011-2149 · Cited by 58
In Vitro Proliferation of Adult Human Beta-Cells
Rutti, S., Sauter, N. S., Bouzakri, K., Prazak, R., Halban, P. A., & Donath, M. Y. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035801 · Cited by 54
Salinari, S., Debard, C., Bertuzzi, A., Durand, C., Zimmet, P., Vidal, H., & Mingrone, G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056258 · Cited by 54
Shaked, M., Ketzinel‐Gilad, M., Ariav, Y., Cerasi, E., Kaiser, Ν., & Leibowitz, G. (2009) · Diabetologia · doi:10.1007/s00125-009-1274-2 · Cited by 67
Dapagliflozin for the treatment of type 2 diabetes: a review of the literature
Narendran, P., & Saeed, M. A. (2014) · Drug Design Development and Therapy · doi:10.2147/dddt.s50963 · Cited by 71
“Furthermore, type 2 diabetes (T2D) is a progressive condition with a gradual and continuing loss of β-cell function.(13,14) This results in deterioration in glycemic control and eventually for the need for insulin-replacement therapy.”
Wang, Q., Chen, J., Wang, Y., Han, X., & Chen, X. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038522 · Cited by 54
Autocrine Action of IGF2 Regulates Adult β-Cell Mass and Function
Modi, H., Jacovetti, C., Tarussio, D., Metref, S., Madsen, O. D., Zhang, F.-P., Rantakari, P., Poutanen, M., Nef, S., Gorman, T., et al. (2015) · Diabetes · doi:10.2337/db14-1735 · Cited by 54
“This compensatory response depends not only on an enhanced secretion capacity of individual b-cells but also, at least in rodents, on an increase in their number (2).”
BackgroundDong, K., Wu, M., Liu, X., Huang, Y., Zhang, D., Wang, Y., Yan, L., & Shi, D. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.10.007 · Cited by 57
Barlow, J., & Affourtit, C. (2013) · Biochemical Journal · doi:10.1042/bj20131002 · Cited by 53
Gao, Y., Kim, S., Lee, Y., & Lee, J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20225601 · Cited by 58
Epigenetic Changes in Islets of Langerhans Preceding the Onset of Diabetes
Admin, A., Ouni, M., Saussenthaler, S., Eichelmann, F., Jähnert, M., Stadion, M., Wittenbecher, C., Rönn, T., Zellner, L., Gottmann, P., et al. (2020) · Diabetes · doi:10.2337/db20-0204 · Cited by 56
“In pancreatic islets, early molecular alterations occur and mediate islet dysfunction before the onset of diabetes (3).”
BackgroundCottle, L., Gan, W. J., Gilroy, I., Samra, J. S., Gill, A. J., Loudovaris, T., Thomas, H. E., Hawthorne, W. J., Kebede, M. A., & Thorn, P. (2021) · Diabetologia · doi:10.1007/s00125-020-05345-8 · Cited by 59
The Interplay of Adipokines and Pancreatic Beta Cells in Metabolic Regulation and Diabetes
Kim, J. M., Oh, C., & Kim, H. (2023) · Biomedicines · doi:10.3390/biomedicines11092589 · Cited by 63
Recent insights of obesity-induced gut and adipose tissue dysbiosis in type 2 diabetes
Patra, D., Banerjee, D., Ramprasad, P., Roy, S., Pal, D., & Dasgupta, S. (2023) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1224982 · Cited by 77
Regulation of beta cell replication
Lee, Y. C., & Nielsen, J. H. (2008) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2008.08.033 · Cited by 63
Thyroid Dysfunction Associated With Follicular Cell Steatosis in Obese Male Mice and Humans
Lee, M. H., Lee, J. U., Joung, K. H., Kim, Y. K., Ryu, M. J., Lee, S. E., Kim, S. J., Chung, H. K., Choi, M. J., Chang, J. Y., et al. (2015) · Endocrinology · doi:10.1210/en.2014-1670 · Cited by 51
“In obesity, excessive accumulation of lipids in pancreatic beta cells causes progressive beta cell dysfunction (14, 15), resulting in early type 2 diabetes and ultimately insulin-dependent diabetes (7, 16, 17).”
BackgroundPodcheko, A., Northcott, P. A., Bikopoulos, G. J., Lee, A., Bommareddi, S. R., Kushner, J. A., Farhang-Fallah, J., & Rozakis-Adcock, M. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.02409-06 · Cited by 56
Regulation of Pancreatic Islet Beta-Cell Mass by Growth Factor and Hormone Signaling
Huang, Y., & Chang, Y. (2014) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-800101-1.00010-7 · Cited by 59
Moin, A. S. M., Dhawan, S., Cory, M., Butler, P. C., Rizza, R. A., & Butler, A. E. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2496 · Cited by 57
Alfar, E. A., Kirova, D., Konantz, J., Birke, S., Mansfeld, J., & Ninov, N. (2017) · Scientific Reports · doi:10.1038/s41598-017-03873-9 · Cited by 56
García-Aguilar, A., Palomino, O. M., Benito, M., & Guillén, C. (2021) · Antioxidants · doi:10.3390/antiox10020142 · Cited by 58
“During the first one, which main event is insulin resistance with normal levels of glycemia, pancreatic β-cells increase their mass by hyperplasia or hypertrophy, with a concomitant insulin and amylin secretion [75].”
BackgroundWeiss, H., Wester-Rosenloef, L., Koch, C., Koch, F., Baltrusch, S., Tiedge, M., & Ibrahim, S. (2012) · Endocrinology · doi:10.1210/en.2012-1296 · Cited by 52
High Density Lipoproteins and Diabetes
Cochran, B. J., Ong, K. L., Manandhar, B., & Rye, K. (2021) · Cells · doi:10.3390/cells10040850 · Cited by 61
“However, prolonged β-cell compensation eventually causes β-cell death, and results in subjects with prediabetes that have impaired fasting glucose and/or impaired glucose tolerance transitioning to complete loss of β-cell function, persistently high blood glucose levels and full blown T2D [35].”
BackgroundREDONDO, M. J., Rodríguez, L. M., Escalante, M., Smith, E. O., Balasubramanyam, A., & Haymond, M. W. (2012) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2012.00875.x · Cited by 56
Exploring Functional β-Cell Heterogeneity In Vivo Using PSA-NCAM as a Specific Marker
Karaca, M., Castel, J., Tourrel‐Cuzin, C., Brun, M., Géant, A., Dubois, M., Catesson, S., Rodriguez, M., Luquet, S. H., Cattan, P., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005555 · Cited by 60
Erion, K. A., Berdan, C. A., Burritt, N. E., Corkey, B. E., & Deeney, J. T. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.620351 · Cited by 52
Mitochondria mediated cell death in diabetes
Szabadkai, G., & Duchen, M. R. (2009) · APOPTOSIS · doi:10.1007/s10495-009-0363-5 · Cited by 63
Wang, L., Zhao, Y., Gui, B., Fu, R., Ma, F., Yu, J. M., Qü, P., Dong, L., & Chen, C. (2011) · Journal of Endocrinology · doi:10.1530/joe-11-0132 · Cited by 58
The importance of synthetic drugs for type 2 diabetes drug discovery
Safavi, M., Foroumadi, A., & Abdollahi, M. R. (2013) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2013.837883 · Cited by 60
“Studies of insulin-resistant animals illustrate an important role for expansion of the b-cell mass and enhanced b-cell function as the compensatory mechanisms [61].”
BackgroundCantley, J., Burchfield, J. G., Pearson, G. L., Schmitz-Peiffer, C., Leitges, M., & Biden, T. J. (2009) · Diabetes · doi:10.2337/db09-0132 · Cited by 52
Emerging roles of β-cell mitochondria in type-2-diabetes
Las, G., Oliveira, M. F., & Shirihai, O. S. (2020) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2019.100843 · Cited by 51
Role of microRNAs in the age-associated decline of pancreatic beta cell function in rat islets
Tugay, K., Guay, C., Marques, A. C., Allagnat, F., Locke, J. M., Harries, L. W., Rutter, G. A., & Regazzi, R. (2015) · Diabetologia · doi:10.1007/s00125-015-3783-5 · Cited by 50
Cho, J. M., Jang, H. W., Cheon, H., Jeong, Y. T., Kim, D., Lim, Y.-M., Choi, S., Yang, E.-K., Shin, C.-Y., Son, M. H., et al. (2010) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2010.10.012 · Cited by 52
Renner, S., Römisch‐Margl, W., Prehn, C. P., Krebs, S., Adamski, J., Göke, B., Blum, H., Suhre, K., Roscher, A. A., & Wolf, E. (2012) · Diabetes · doi:10.2337/db11-1133 · Cited by 55
β- cell dynamics in type 2 diabetes and in dietary and exercise interventions
Lv, C.-A., Sun, Y., Zhang, Z. Y., Aboelela, Z., Qiu, X., & Meng, Z. (2022) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjac046 · Cited by 62
Bo, J., Xie, S., Guo, Y., Zhang, C., Guan, Y., Li, C., Lü, J., & Meng, Q. H. (2015) · Journal of Diabetes Research · doi:10.1155/2016/2029854 · Cited by 57
Metadata
- Authors
- Prentki, M.
- Affiliations
- Centre Hospitalier de l’Université de Montréal (CA)
- Corresponding author
- Prentki, M.
- ORCID
- Prentki, M.
- Venue
- Journal of Clinical Investigation
- Published
- 2006-07-03
- Volume
- 116
- Issue
- 7
- Pages
- 1802-1812
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC1483155
- OpenAlex
- W1598254642
- Cited by
- 1,690
- References
- 132
- Citations by year
- 2026: 52 · 2025: 52 · 2024: 46 · 2023: 54 · 2022: 68 · 2021: 95 · 2020: 95 · 2019: 111 · 2018: 90 · 2017: 109 · 2016: 112 · 2015: 107 · 2014: 131 · 2013: 97 · 2012: 98
- FWCI
- 13.11
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- ANU Open Research (Australian National University) (submittedVersion)
- Funders
- ACT Government
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK063356, DK63356)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- beta-cell failure, type 2 diabetes, obesity, beta-cell compensation, beta-cell mass expansion, insulin resistance, genetic susceptibility, intrauterine factors, environmental risk factors, beta-cell dysfunction
- MeSH terms
- Animals, Diabetes Mellitus, Type 2, Humans, Insulin Resistance, Disease Progression, Genetic Predisposition to Disease, Insulin-Secreting Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.